{"id":842,"date":"2024-10-11T06:37:38","date_gmt":"2024-10-11T06:37:38","guid":{"rendered":"https:\/\/vichsec.org\/guidline\/stability-testing-requirements-for-new-dosage-forms\/"},"modified":"2024-10-11T06:37:52","modified_gmt":"2024-10-11T06:37:52","slug":"stability-testing-requirements-for-new-dosage-forms","status":"publish","type":"guideline","link":"https:\/\/vichsec.org\/fr\/guidline\/stability-testing-requirements-for-new-dosage-forms\/","title":{"rendered":"Stability Testing: Requirements for New Dosage Forms"},"content":{"rendered":"<p>VICH GL4 Annex to the VICH guidelines on Stability Testing for New Drugs and Products (Quality &#8211; Stability) &#8211; Implemented in May 2000<\/p>\n","protected":false},"menu_order":118,"template":"","meta":[],"guideline_category":[121],"class_list":["post-842","guideline","type-guideline","status-publish","hentry","guideline_category-pharmaceuticals-pharma-quality-pharma-stability"],"_links":{"self":[{"href":"https:\/\/vichsec.org\/fr\/wp-json\/wp\/v2\/guideline\/842","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/vichsec.org\/fr\/wp-json\/wp\/v2\/guideline"}],"about":[{"href":"https:\/\/vichsec.org\/fr\/wp-json\/wp\/v2\/types\/guideline"}],"wp:attachment":[{"href":"https:\/\/vichsec.org\/fr\/wp-json\/wp\/v2\/media?parent=842"}],"wp:term":[{"taxonomy":"guideline_category","embeddable":true,"href":"https:\/\/vichsec.org\/fr\/wp-json\/wp\/v2\/guideline_category?post=842"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}